- Home
- ELAB vs SLRX Comparison
ELAB vs SLRX Comparison
Compare ELAB & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.84
Company Overview
Basic Information| Metric | ELAB | SLRX |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 3.6M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELAB | SLRX |
|---|---|---|
| Price | $5.81 | $0.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 501.4K | 348.2K |
| Earning Date | 03-27-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $285,948.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.62 | $0.51 |
| 52 Week High | $398.86 | $108.00 |
Technical Indicators
Market Signals| Indicator | ELAB | SLRX |
|---|---|---|
| Relative Strength Index (RSI) | 72.16 | 47.16 |
| Support Level | $1.25 | $0.51 |
| Resistance Level | $9.59 | $0.68 |
| Average True Range (ATR) | 0.76 | 0.06 |
| MACD | 0.46 | 0.07 |
| Stochastic Oscillator | 55.22 | 82.81 |
Price Performance
Historical Comparison ELAB
SLRX
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.